RET kinase inhibitor
orally efficacious in XG but narrow TI
from data mining of internal matter and opt.
ACS Med. Chem. Lett. Feb. 12, 2020
Novartis (GNF), San Diego, CA
WF-47-JS03
(Novartis (GNF) oral in vivo RET kinase inhibitor)
Drug Hunter
Drug Hunter
(Novartis (GNF) oral in vivo RET kinase inhibitor)